To the full analysis
Qiagen stock: growth
QGENQiagen reported $2.09B in revenue for fiscal 2025, up 5.7% on the prior year, up 2.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
8.2%
per year from 2006 to 2025, per share 6.1%
Earnings (Annual rate)
9.9%
per year from 2006 to 2025, per share 7.8%
Free cash flow (Annual rate)
10.7%
per year from 2006 to 2025, per share 8.5%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 2.2% | 5.0% | 8.2% |
| Revenue per share | 3.6% | 5.8% | 6.1% |
| Earnings | 3.4% | 12.6% | 9.9% |
| Earnings per share | 44.0% | 13.6% | 7.8% |
| Free cash flow | 19.2% | 8.5% | 10.7% |
| Free cash flow per share | 20.8% | 9.4% | 8.5% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $465.78M | $70.54M | $66.13M |
| 2007 | $649.77M | $50.12M | $26.2M |
| 2008 | $892.98M | $89.03M | $115.08M |
| 2009 | $1.01B | $137.77M | $147.64M |
| 2010 | $1.09B | $144.31M | $126.84M |
| 2011 | $1.17B | $96.04M | $123.39M |
| 2012 | $1.25B | $129.51M | $116.8M |
| 2013 | $1.3B | $69.07M | $140.26M |
| 2014 | $1.34B | $116.37M | $190.96M |
| 2015 | $1.28B | $130.15M | $200.02M |
| 2016 | $1.34B | $80.4M | $247.68M |
| 2017 | $1.42B | $40.39M | $162.37M |
| 2018 | $1.5B | $190.38M | $208.73M |
| 2019 | $1.53B | −$41.46M | $55.96M |
| 2020 | $1.87B | $359.19M | $188.04M |
| 2021 | $2.25B | $512.6M | $432.47M |
| 2022 | $2.14B | $423.21M | $565.93M |
| 2023 | $1.97B | $341.3M | $296.65M |
| 2024 | $1.98B | $83.59M | $506.38M |
| 2025 | $2.09B | $424.88M | $453.28M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 31 Jul 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.